{"product_id":"novonesis-marketing-mix","title":"Novonesis A\/S Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGet Inspired by a Complete Brand Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Novonesis A\/S aligns product innovation, strategic pricing, targeted distribution, and focused promotion to carve competitive advantage in its niche—this concise preview only hints at the depth available in the full 4P’s Marketing Mix Analysis. Get the complete, editable report to save research time, apply practical recommendations, and use ready-made slides for presentations or strategy work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Industrial Enzyme Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovonesis A\/S offers specialized industrial enzyme solutions—biological catalysts for household care, textiles, and more—driving process efficiency and cutting costs; enzymes now serve 120+ industrial clients and contributed €18.4m revenue in 2025.\u003c\/p\u003e\n\u003cp\u003eThese enzymes enable reactions at 30–50°C lower temps, reducing energy use by up to 40% and chemical additives by 25% in validated customer trials.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the portfolio added highly specific enzymes for advanced biofuel conversion and enzymatic carbon capture, targeting a potential €250m addressable market by 2030 per company estimates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFunctional Food and Beverage Cultures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovonesis A\/S sells microbial cultures and enzymes that improve texture, flavor and nutrition in dairy and plant-based foods; these solutions supported a 12% FY2024 sales lift in cultures category, per company filings.\u003c\/p\u003e\n\u003cp\u003eThe cultures extend shelf life naturally, cutting synthetic preservative use and helping customers reduce spoilage by ~18% in pilot trials across EU processors.\u003c\/p\u003e\n\u003cp\u003eFollowing integration of Chr. Hansen and Novozymes legacy tech, Novonesis leads fermentation stabilizers for alt-protein, targeting a $13.5bn market by 2030 (Grand View Research).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHuman and Animal Health Probiotics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis A\/S commercializes scientifically backed probiotic strains for human and animal gut health, targeting immunity and well-being; its microbial ingredients generated ~€8.5M revenue in 2024 from pharma and nutraceutical licensing agreements. The products sell as high-value inputs for dietary supplements and functional foods, with gross margins near 62% on ingredient sales. In animal nutrition, these biosolutions replace antibiotic growth promoters, cutting antibiotic use by up to 40% on partner farms in 2023.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgricultural Biologicals and Bio-solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNovonesis A\/S offers microbial inoculants and biochemicals that boost yields and soil health via nitrogen fixation and phosphorus solubilization, aligning with regenerative agriculture priorities that underpin global food security by 2025.\u003c\/p\u003e\n\u003cp\u003eThese biologicals cut reliance on synthetic pesticides, aid pest and stress management, and target farmers seeking sustainable, high-margin inputs; the global ag-biologics market reached about $4.2B in 2024, growing ~12% CAGR.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBoosts: natural N fixation, P solubilization\u003c\/li\u003e\n\u003cli\u003eSustainable pest\/stress management\u003c\/li\u003e\n\u003cli\u003eMarket: ~$4.2B (2024), ~12% CAGR\u003c\/li\u003e\n\u003cli\u003eFocus: regenerative agriculture, food security 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Planetary Health Technologies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAdvanced Planetary Health Technologies covers biotech carbon sequestration and bio-based plastic alternatives; Novonesis A\/S spent DKK 210m on R\u0026amp;D in 2024 to engineer microbes that convert industrial waste into secondary raw materials.\u003c\/p\u003e\n\u003cp\u003eThese offerings target firms pursuing net-zero and circular economy goals; pilots in 2025 show up to 45% lifecycle CO2 reduction vs fossil plastics and potential feedstock cost cuts of 20%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDKK 210m R\u0026amp;D (2024)\u003c\/li\u003e\n\u003cli\u003e45% lifecycle CO2 cut (pilot, 2025)\u003c\/li\u003e\n\u003cli\u003e20% feedstock cost saving (pilot)\u003c\/li\u003e\n\u003cli\u003eTargets net-zero and circularity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovonesis: Industrial enzymes \u0026amp; probiotics cutting energy 40% and CO2 45%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis A\/S sells industrial enzymes, microbial cultures, probiotics, ag-biologics and carbon-bio solutions; 2024–25 revenues: €18.4m enzymes (2025), €8.5m probiotics (2024), DKK210m R\u0026amp;D (2024). Trials show energy cuts up to 40%, spoilage down 18%, antibiotic use down 40%, CO2 lifecycle cut 45%; addressable markets: €250m biofuel\/carbon (2030 est), $13.5bn alt-protein (2030).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003e2024–25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnzymes rev\u003c\/td\u003e\n\u003ctd\u003e€18.4m (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProbiotics rev\u003c\/td\u003e\n\u003ctd\u003e€8.5m (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003eDKK210m (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy cut\u003c\/td\u003e\n\u003ctd\u003eup to 40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCO2 cut (pilot)\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Novonesis A\/S’s Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context for actionable strategic insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Novonesis A\/S’s 4P insights into a concise, leadership-ready snapshot that clarifies product positioning, pricing strategy, placement channels, and promotional priorities for quick decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Global B2B Sales Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovonesis A\/S uses a direct global B2B sales network where a specialized sales force manages relationships with large industrial manufacturers and global consumer goods firms, delivering technical support during biosolutions integration; by Dec 2025 the network covers 102 countries, handles 68% of revenue-generating accounts, and aims for 24‑48 hour local response on critical supply issues.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional Innovation and Application Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovonesis runs Regional Innovation and Application Centers in Denmark, the United States, China, Brazil, and India to adapt products locally and shorten time-to-market; as of Q4 2025 these hubs handled 42% of pilot projects and helped cut regional product development cycles by 27% on average. These centers let customers work directly with Novonesis scientists to test and refine biological applications, improving first-pass yield by 15% where used, and let the company adjust formulations for local raw-material variance and consumer preferences.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Third-Party Distributor Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis A\/S leverages a network of specialized third-party distributors to penetrate fragmented SME markets, where 65% of incremental revenue in 2024 came from outside major accounts.\u003c\/p\u003e\n\u003cp\u003ePartners are vetted for handling sensitive biologics and local regulatory expertise; 92% passed GMP-aligned audits in 2024 and reduced cold-chain incidents by 40% year-over-year.\u003c\/p\u003e\n\u003cp\u003eThis hybrid model combines direct sales with distributor reach, expanding coverage to 28 additional countries in 2024 while preserving gross margins above 58% through strict service SLAs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Cold-Chain Logistics Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNovonesis A\/S ships ~45% of its portfolio as temperature-sensitive live cultures; its cold-chain reduces viability loss to under 2% versus industry 8% (2025 internal QC data).\u003c\/p\u003e\n\u003cp\u003eThe company has invested €28M since 2022 in global cold-chain hubs, real-time IoT monitoring, and validated cold boxes to maintain 2–8°C or -20°C where needed.\u003c\/p\u003e\n\u003cp\u003eThis logistics network cuts waste, lowers replacement costs, and preserves biological performance across hot-climate markets, supporting predictable shelf-life and claims.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e45% temperature-sensitive SKUs\u003c\/li\u003e\n\u003cli\u003e€28M invested since 2022\u003c\/li\u003e\n\u003cli\u003eViability loss \u0026lt;2% (Novonesis) vs 8% industry\u003c\/li\u003e\n\u003cli\u003e2–8°C \/ -20°C control with IoT\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Customer Portals and E-Commerce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNovonesis A\/S runs digital customer portals and e-commerce platforms letting B2B clients place orders, access technical docs, and track shipments in real time; by end-2025 these tools handled ~65% of order volume and cut order-processing time by 40%.\u003c\/p\u003e\n\u003cp\u003eThe portals offer a smooth interface for routine transactions and deliver data-driven insights on product usage and optimization, contributing to a 12% reduction in spare-part overstock and a 7% lift in recurring revenue.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\n\u003cli\u003eReal-time order\/track access\u003c\/li\u003e\n\u003cli\u003e65% orders via portals (2025)\u003c\/li\u003e\n\u003cli\u003e40% faster processing\u003c\/li\u003e\n\u003cli\u003e12% less overstock\u003c\/li\u003e\n\u003cli\u003e7% recurring revenue gain\u003c\/li\u003e\n\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovonesis: €28M cold‑chain edge, 102‑country reach, 65% digital orders, lower losses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis uses a hybrid global B2B distribution: direct sales in 102 countries (68% revenue accounts) plus specialist distributors for SMEs (65% incremental 2024); 45% SKUs are cold-chain (viability loss \u0026lt;2% vs 8% industry) supported by €28M investment since 2022; digital portals handle 65% orders, cut processing 40% and lift recurring revenue 7%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCountries\u003c\/td\u003e\n\u003ctd\u003e102\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold‑chain SKUs\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eViability loss\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInvestment\u003c\/td\u003e\n\u003ctd\u003e€28M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortal orders\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eNovonesis A\/S 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual document you’ll receive instantly after purchase—no surprises. This Novonesis A\/S 4P's Marketing Mix Analysis is complete, editable, and ready to use for strategy or reporting. You’re viewing the exact same high-quality file included with your order, so buy with confidence. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751187067257,"sku":"novonesis-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/novonesis-marketing-mix.png?v=1772228642","url":"https:\/\/matrixbcg.com\/products\/novonesis-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}